Nautilus Biotechnology, Inc.
NASDAQ:NAUT
2.87 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 8.212 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.597 | 1.591 | 1.59 | 1.515 | 1.42 | 1.171 | 0.921 | 0.86 | 0.829 | 0.806 | 0.263 | 0.277 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -1.597 | -1.591 | 6.622 | -1.515 | -1.42 | -1.171 | -0.921 | -0.86 | -0.829 | -0.806 | -0.263 | -0.277 | -0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.806 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 11.924 | 12.414 | 12.466 | 11.996 | 11.912 | 10.877 | 9.587 | 9.571 | 8.856 | 9.658 | 9.893 | 8.244 | 6.38 | 4.835 | 3.894 | 3.317 | 2.751 | 2.47 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 8.353 | 8.677 | 7.535 | 7.079 | 7.104 | 7.183 | 6.717 | 6.249 | 6.616 | 6.364 | 6.923 | 6.324 | 4.317 | 3.582 | 1.426 | 0.71 | 0.649 | 4.127 | 0.355 | 0.178 | 0.088 | 0.154 | 111.684 |
| Selling & Marketing Expenses
| -1.085 | 7.593 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.268 | 7.602 | 7.535 | 7.079 | 7.104 | 7.183 | 6.717 | 6.249 | 6.616 | 6.364 | 6.923 | 6.324 | 4.317 | 3.582 | 1.426 | 0.71 | 0.649 | 4.127 | 0.355 | 0.178 | 0.088 | 0.154 | 111.684 |
| Other Expenses
| -0.019 | 0 | -0.056 | 3.197 | -0.014 | 3.095 | 0.008 | -0.132 | 0.783 | 0.259 | 0.127 | 0.064 | -0.016 | 0.008 | -0.032 | 0.049 | 0.045 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 19.192 | 20.016 | 20.001 | 19.075 | 19.016 | 18.06 | 16.304 | 15.82 | 15.472 | 16.022 | 16.816 | 14.568 | 10.697 | 8.417 | 5.32 | 4.027 | 3.4 | 4.127 | 0.355 | 0.178 | 0.088 | 0.154 | 111.684 |
| Operating Income
| -20.789 | -21.607 | -17.024 | -15.878 | -15.808 | -18.06 | -17.225 | -15.82 | -15.472 | -16.022 | -16.689 | -14.568 | -10.697 | -8.417 | -5.32 | -4.027 | -3.4 | -4.127 | -0.355 | -0.178 | -0.088 | -0.154 | -111.684 |
| Operating Income Ratio
| 0 | 0 | -2.073 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.779 | 2.877 | -0.056 | 3.197 | -0.014 | 3.095 | 3.816 | 1.757 | 0.783 | 0.259 | 0.127 | 0.064 | -0.016 | 0.008 | -0.032 | 0.049 | 0.045 | 0.857 | 0.741 | 0.795 | 0.945 | 0.872 | 738.284 |
| Income Before Tax
| -18.01 | -18.73 | -17.024 | -15.878 | -15.808 | -14.965 | -13.409 | -14.063 | -14.689 | -15.763 | -16.689 | -14.504 | -10.713 | -8.409 | -5.352 | -3.978 | -3.355 | -3.27 | 0.385 | 0.617 | 0.857 | 0.719 | 626.6 |
| Income Before Tax Ratio
| 0 | 0 | -2.073 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 1.548 | -3.033 | 3.197 | -3.222 | -3.095 | 2.886 | 1.889 | -0.783 | -0.259 | 0.606 | -0.734 | 0.312 | 0 | 0 | 0 | -0.169 | 0.699 | 0.694 | 0.75 | 0.904 | 0.832 | 0 |
| Net Income
| -18.01 | -18.73 | -17.024 | -15.878 | -15.808 | -11.87 | -16.295 | -15.952 | -13.906 | -15.504 | -16.689 | -14.504 | -10.713 | -8.409 | -5.352 | -3.978 | -3.355 | -3.27 | 0.385 | 0.617 | 0.857 | 0.719 | 626.6 |
| Net Income Ratio
| 0 | 0 | -2.073 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.14 | -0.15 | -0.14 | -0.13 | -0.13 | -0.095 | -0.13 | -0.13 | -0.11 | -0.12 | -0.13 | -0.12 | -0.086 | -0.068 | -0.17 | -0.13 | -0.12 | -0.45 | 0.054 | 0.086 | 0.12 | 0.1 | 87.18 |
| EPS Diluted
| -0.14 | -0.15 | -0.14 | -0.13 | -0.13 | -0.095 | -0.13 | -0.13 | -0.11 | -0.12 | -0.13 | -0.12 | -0.086 | -0.068 | -0.17 | -0.13 | -0.12 | -0.45 | 0.054 | 0.086 | 0.12 | 0.1 | 87.18 |
| EBITDA
| -19.192 | -20.016 | -18.411 | -19.075 | -17.555 | -16.889 | -16.304 | -14.96 | -14.643 | -15.216 | -15.947 | -14.568 | -10.085 | -7.79 | -4.722 | -3.442 | -3.4 | -3.27 | 0.385 | 0.617 | 0.857 | 0.719 | 626.6 |
| EBITDA Ratio
| 0 | 0 | -2.242 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |